Learn
Explore our list of resources
Depending on your rare disease journey, Global Genes provides you with the resource and community to enhance your learning.
Featured
Gene-Based Diagnosis 101: How to Successfully Navigate the Diagnostic Journey
As scientific innovation in genomic medicine continues to provide more hope for therapeutic options, there is a […]
Read moreA Case for Whole Genome Sequencing
The ability to diagnose rare genetic diseases through the use of genetic sequencing has improved to a […]
Read moreAdvances in Rare Immunological Diseases
Recent advances in rare immunological diseases have raised the exciting potential of cures for some disorders. Hear […]
Read moreDevelopmental Delays After Factor V Leiden Pregnancy
by Tiffany Burnette I was diagnosed with Factor V Leiden when I was pregnant with Sammy. While […]
Read morePatient Stories
Living and Advocating Through a Complex Medical Journey: Erythromelalgia, Visual Snow Syndrome, and Autoimmune Dysregulation
Hello, my name is Sierra Domb. Since childhood, I have experienced Erythromelalgia (EM) and Autoimmune Dysregulation (AD). […]
Read moreLiving with Brugada Syndrome
Brugada is insidious, especially for someone my age. It tends to “hide” in the ECG. Many times, it looks normal… but it isn’t. And with the myocarditis I had at the same time, it was even harder to get a correct diagnosis. The doctors didn’t know whether the findings were due to Brugada or to myocarditis. After my hospitalization, and after I suffered a fainting episode, it was finally decided that I should be implanted with a defibrillator (ICD). When it happened, I felt like life was given back to me.
Read moreHe Is Three. His Voice Isn’t Lost —It’s Waiting to Be Heard.
By the time a genetic diagnosis of a rare mutation in the PPP3CA gene finally arrived, critical months — even years — had slipped away. Milestones were missed while we waited for answers. Early concerns were minimized, and our pleas for help were too often brushed aside until delays became severe. That delay is not just a bureaucratic failure; it is lost opportunity — lost time for therapies that could have helped him build strength, communication, and independence.
Read moreThe Beginning of Our Lowe Syndrome Journey
By Caroline Tsai The sun blazes overhead without a cloud in sight. Only a high of 90 […]
Read moreInvincible Never Invisible: A Decade of InvisiYouth
I was competitive tennis player as a teen and was unfortunately injured in training, which resulted in dealing with an injury and neurovascular condition that changed the trajectory of my life. I was thrust into the world of living with a chronic illness, years of trying to find proper diagnoses and treatments, all while balancing life as a teen/young adult. During this entire young adult experience, my doctors would tell me “wait” till they could fix my health to live my life fully… I created InvisiYouth out of my love of philanthropy, and my newfound passion to giving a voice for the young adult population living with all chronic illnesses and disabilities for the non-medical aspects of their lives with health struggles.
Read moreBeauty in Being Rare
Classical HCU is a condition in which my liver has a defective enzyme that is supposed to break down methionine. Instead, it builds up and turns into homocysteine, which is extremely toxic to your body. These elevated levels can result in blood clots, strokes, and other life-threatening complications. I follow an extremely restrictive low-protein diet—only about 10 grams of whole protein per day—alongside a methionine-free formula, the medication called betaine, and a cocktail of vitamins and supplements.
Read moreLatest News
Savara’s Early Access Program
Savara’s Early Access Program (EAP) for molgramostim inhalation solution (molgramostim) in Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune […]
Read morePublication Announcement — RARE-X: Advancing Rare Disease Research Through Patient-Driven Data
Global Genes is excited to announce “RARE-X: A patient-driven approach for collecting symptom and patient-reported outcome data […]
Read moreAccelerating Rare Disease Research Through Collaboration: Global Genes and Notre Dame Launch the Research Acceleration Program
Global Genes and University of Notre Dame have partnered to launch the Research Acceleration Program, a collaborative […]
Read moreRARE Advocacy Exchange Session 8, Knowing Your Rare Rights
This session recording is from Oct. 16, 2025 Rare Advocacy Exchange Session 8: Knowing the Rights for […]
Read moreGlobal Genes Guide to Starting a Nonprofit Patient Advocacy Organization
This Global Genes Quick Guide is a resource for advocates focused on pressing topics causing challenges in […]
Read moreRARE Advocacy Exchange Session 7, Getting a Precise Genetic Diagnosis
This session recording is from Sept. 18, 2025 Rare Advocacy Exchange Session 7: Getting A Precise Diagnosis […]
Read moreIndustry News
Viridian Drug Meets Main Goals in TED Trial, but Shares Sink on Results
Rare Daily Staff Viridian Therapeutics said its experimental drug elegrobart met the main goals of a late-stage […]
Read moreFDA Grants Accelerated Approval to Rocket’s Gene Therapy for LAD-1
Rare Daily Staff The U.S. Food and Drug Administration has granted accelerated approval to Rocket Pharmaceuticals’ gene […]
Read moreKaryopharm Reports Mixed Study Result, Raises $30 Million
Rare Daily Staff Karyopharm Therapeutics reported mixed but promising results from a clinical trial in myelofibrosis, a […]
Read moreHow a Foundation Built Its Own Drug Program for an Ultra-Rare Disease
Schaaf-Yang syndrome is an ultra-rare neurodevelopmental disorder that is closely related to but distinct from Prader-Willi syndrome. […]
Read moreFDA Grants Accelerated Approval to Denali’s Hunter Syndrome ERT
Rare Daily Staff The U.S. Food and Drug Administration granted accelerated approval to Denali Therapeutics’ Avlayah, a […]
Read moreAI System Has Potential to Shorten Rare Disease Diagnostic Odyssey
Rare Daily Staff A new artificial intelligence system could help shorten the diagnostic odyssey families face for […]
Read moreImmutrin Raises $87 Million to Advance ATTR-CM Therapy
Rare Daily Staff U.K.-based Immutrin raised $87 million (£65 million) in an oversubscribed series A financing to […]
Read moreCIRM Approves $100 Million for Platform-Based Gene Therapies for Rare Diseases
Rare Daily Staff The California Institute for Regenerative Medicine is launching a new funding initiative aimed at […]
Read moreAlfasigma wins FDA approval for liver disease itch treatment
Rare Daily Staff The U.S. Food and Drug Administration has approved Alfasigma’s linerixibat to treat severe itching […]
Read moreGenetic Counseling
Global Genes Guide to Genetic Diagnosis
This Global Genes Quick Guide is a resource for advocates focused on pressing topics causing challenges in […]
Read moreGlobal Genes 2025 Quick Guide Series
We are excited to announce the launch of a new series of Quick Guides for the […]
Read moreAngelina Spreading Light, Love, and Inspiration on CASK Gene Awareness Day
To recognize CASK Gene Awareness Day on July 15, Global Genes reached out to Giovi Moschoudis, mother […]
Read moreTeam Wally Inspires During Fragile X Awareness Month
To recognize Fragile X Awareness Month in July, Global Genes reached out to National Fragile X Foundation, […]
Read moreFrom First Symptoms to Advocate for Transverse Myelitis
To recognize Transverse Myelitis Awareness Month in June, Global Genes reached out to The MOG Project, a […]
Read moreMoving from Awareness to Action after Sickle Cell Disease Diagnosis
Karen L. Proudford, Ph.D. is the President of Williams E. Proudford Sickle Cell Fund, Inc., and daughter […]
Read moreResearch Readiness
UC Berkeley Partners with BioMarin to Accelerate Rare Disease Research
The UC Berkeley Molecular Therapeutics Initiative (MTI) has entered into a new research collaboration with BioMarin Pharmaceutical […]
Read moreOxford-Harrington Awards Nearly $900K in Friedreich’s Ataxia Grants
Rare Daily Staff The Oxford-Harrington Rare Disease Centre’s FA Alliance Innovation Fund has awarded funding to five […]
Read moreKingsmore Stepping Down from Rady Children’s Institute for Genomic Medicine
Rare Daily Staff Stephen Kingsmore, a pioneer in the clinical use of rapid whole genome sequencing, will […]
Read moreA Gene Editing Approach to Work Across Multiple Diseases
Rare Daily Staff Researchers at the Broad Institute have developed a new genome-editing strategy that could potentially […]
Read moreNIH Makes $14.4 Million Award to Launch Initiative to Bring WGS to Newborn Screening
NIH Makes $14.4 Million Award to Launch Initiative to Bring WGS to Newborn Screening Rare Daily Staff […]
Read moreNIH awards Baylor $15.6 million to fund two rare diseases consortia
NIH awards Baylor $15.6 Million to Fund Two Rare Diseases Consortia Rare Daily Staff The National Institutes […]
Read moreMental Health & Wellness
RARE Advocacy Exchange Session 6 : Grieving a RARE Diagnosis
Rare disease grief differs from the grief we commonly associate with losing a loved one to death. […]
Read moreA Student’s Perspective: Lessons from the 2025 RARE Drug Development Symposium
During my first week as a Harvard College junior, I was delighted to be given the opportunity […]
Read moreGlobal Genes Guide to Securing a State Proclamation for Rare Disease Awareness
This Global Genes Quick Guide is a resource for advocates focused on pressing topics causing challenges in […]
Read moreGlobal Genes Guide to Your Rare Rights
This Global Genes Quick Guide is a resource for advocates focused on pressing topics causing challenges in […]
Read moreGlobal Genes Guide to Fundraising
This Global Genes Quick Guide is a resource for advocates focused on pressing topics causing challenges in […]
Read moreGlobal Genes Guide to Comprehensive Fundraising Strategic Documents
This Global Genes Quick Guide is a resource for advocates focused on pressing topics causing challenges in […]
Read moreRARE Advocacy Exchange Session 5 : Interacting with FDA: PFDD and Listening Sessions
If your rare disease is likely to have a clinical trial for a drug or treatment come […]
Read moreA PAG Leader Guide to Presenting the Patient Experience at Your EL-PFDD Session with the FDA.
A Global Genes Quick Guide is a resource for advocates focused on pressing topics causing challenges in […]
Read moreLove, Advocacy, and Belonging: Reflections from a Rare Disease Ally
By Nicole Boice, Chief Mission Officer, Global Genes As Chief Mission Officer at Global Genes—and as the […]
Read moreRARE Daily
FDA Expands Approval of Rhythm’s Imcivree
Rare Daily Staff The U.S. Food and Drug Administration has granted expanded approval to Rhythm Pharmaceuticals’ obesity […]
Read moreFDA Grants Breakthrough Therapy for Sanofi’s Type 3 Gaucher Disease Drug
Rare Daily Staff The U.S. Food and Drug Administration granted Breakthrough Therapy designation to Sanofi’s experimental drug […]
Read moreFrom Bloodletting to Breakthroughs in PV
Polycythemia vera is a chronic blood cancer in which bone marrow stem cells acquire mutations that drive […]
Read moreRhythm Drug Fails in Phase 3 Study in Genetic Obesity
Rare Daily Staff Rhythm Pharmaceuticals said that its late-stage study of its drug setmelanotide for rare genetic […]
Read moreSentynl Therapeutics to License Experimental Progeria Drug
Rare Daily Staff Sentynl Therapeutics has entered into an agreement to license an experimental drug for Hutchinson-Gilford […]
Read moreNatera Launches New WGS Test
Natera said it has launched a new genomic testing platform designed to help diagnose rare diseases faster. […]
Read moreSearch the RARE List
For more resources, disease-specific information, and news, search our RARE List- an extensive list of rare diseases and rare conditions.
Search Our Full RARE List